Pages Tagged with "Jianhua Yu"

RESEARCH ALERT: City of Hope scientists reveal how XBP1s interacts with IL-15 to enhance the survival of natural killer cells
Discovery suggests a promising therapeutic approach for fighting cancers FINDINGS A new study published in Science Immunology points to a promising therapeutic approach for future cancer treatments based on natural...
City of Hope scientists develop new potential treatment for brain tumors
CONTACT Letisia Marquez626-476-7593lemarquez@coh.org A novel way of attracting immune cells to fight brain tumors could improve survival rates for one of the deadliest types of cancer LOS ANGELES ...
City of Hope physicians/scientists lead multiple, innovative COVID-19 research projects
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   Chimeric antigen receptor (CAR)-NK cell therapy to treat the virus is one of more than two dozen COVID-19 research projects underway   DUARTE, Calif...
City of Hope scientists delving into COVID-19 research
As City of Hope’s research to find better treatments for cancer and diabetes continues during the COVID-19 pandemic, the institution’s renowned physician-scientists are also using their expertise to attack the deadly...
City of Hope and CytoImmune announce study demonstrating novel off-the-shelf chimeric antigen receptor (CAR) natural killer (NK) cell-based therapy against pancreatic cancer
Contacts: City of Hope Letisia Marquez lemarquez@coh.org 626-476-7593   CytoImmune William Rosellini will@cytoimmune.com   Gastroenterology study demonstrates therapeutic efficacy of off-the-shelf CAR NK cell-based therapy targeting prostate stem cell...
City of Hope study finds a novel mechanism of action for natural killer cells in checkpoint inhibitor therapy for cancer
CONTACT Letisia Marquez 626-218-3398 lemarquez@coh.org   PD-L1+ NK cells may prove to be another important immune effector cell for checkpoint inhibitor-based cancer immunotherapy     DUARTE, Calif. — PD-L1...
City of Hope Researchers Present Breakthrough Findings at AACR 2021
City of Hope will showcase breakthrough research and innovative studies at the first week of the American Association for Cancer Research (AACR) Annual Meeting 2021, which will take place virtually...
City of Hope enters licensing agreements with CytoImmune Therapeutics Inc. to develop portfolio of chimeric antigen receptor-natural killer therapies
CONTACT City of Hope Zen Vuong 626-409-9367 zvuong@coh.org   CytoImmune William Rosellini will@cytoimmune.com   License and development agreements will advance several immunotherapies   Duarte and Monrovia, Calif. – City of...
City of Hope scientists highlight new findings at AACR 2021
CONTACT Zen Vuong 626-409-9367zvuong@coh.org   These important studies could one day lead to new cancer treatments and improved health equity — developments that will improve health outcomes for cancer...
Anti-PD-L1 checkpoint inhibitors: Decoding the mystery
An extensive study conducted by City of Hope experts Michael Caligiuri, M.D., president of City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair, and Jianhua Yu, Ph.D...
Subscribe to Jianhua Yu